{
  "id": "meld_score_original",
  "title": "MELD Score (Original, Pre-2016, Model for End-Stage Liver Disease)",
  "description": "Quantifies end-stage liver disease for transplant planning using the original pre-2016 formula without sodium",
  "category": "gastroenterology",
  "version": "2002",
  "parameters": [
    {
      "name": "creatinine",
      "type": "float",
      "required": true,
      "description": "Serum creatinine in mg/dL. If patient on hemodialysis, use 4.0. If <1.0, use 1.0",
      "unit": "mg/dL",
      "validation": {
        "min": 0.01,
        "max": 40.0
      }
    },
    {
      "name": "bilirubin",
      "type": "float",
      "required": true,
      "description": "Total bilirubin in mg/dL. If <1.0, use 1.0",
      "unit": "mg/dL",
      "validation": {
        "min": 0.00000001,
        "max": 50.0
      }
    },
    {
      "name": "inr",
      "type": "float",
      "required": true,
      "description": "International Normalized Ratio (INR). If <1.0, use 1.0",
      "unit": "",
      "validation": {
        "min": 0.1,
        "max": 20.0
      }
    },
    {
      "name": "dialysis",
      "type": "string",
      "required": true,
      "description": "Has the patient had hemodialysis at least twice in the past week?",
      "options": ["yes", "no"],
      "validation": {
        "enum": ["yes", "no"]
      }
    }
  ],
  "result": {
    "name": "meld_score",
    "type": "integer",
    "unit": "points",
    "description": "Original MELD score for liver disease severity"
  },
  "interpretation": {
    "ranges": [
      {
        "min": 6,
        "max": 9,
        "stage": "Low Risk",
        "description": "MELD ≤9",
        "interpretation": "3-month mortality approximately 1.9%. Lower priority for liver transplant. Continue routine monitoring."
      },
      {
        "min": 10,
        "max": 19,
        "stage": "Moderate Risk",
        "description": "MELD 10-19",
        "interpretation": "3-month mortality approximately 6.0%. Moderate priority for liver transplant. Consider hepatology referral if not established."
      },
      {
        "min": 20,
        "max": 29,
        "stage": "High Risk",
        "description": "MELD 20-29",
        "interpretation": "3-month mortality approximately 19.6%. High priority for liver transplant. Requires close monitoring."
      },
      {
        "min": 30,
        "max": 39,
        "stage": "Very High Risk",
        "description": "MELD 30-39",
        "interpretation": "3-month mortality approximately 52.6%. Very high priority for liver transplant. Consider ICU-level care."
      },
      {
        "min": 40,
        "max": 40,
        "stage": "Extremely High Risk",
        "description": "MELD ≥40",
        "interpretation": "3-month mortality approximately 71.3%. Highest priority for liver transplant. Requires intensive care."
      }
    ]
  },
  "references": [
    "Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001 Feb;33(2):464-70. doi: 10.1053/jhep.2001.22172.",
    "Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology. 2003 Jan;124(1):91-6. doi: 10.1053/gast.2003.50016.",
    "Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000 Apr;31(4):864-71. doi: 10.1053/he.2000.5852."
  ],
  "formula": "MELD = (0.957 × ln(Cr) + 0.378 × ln(bilirubin) + 1.120 × ln(INR) + 0.643) × 10",
  "notes": [
    "This is the original pre-2016 MELD formula without sodium",
    "For patients on hemodialysis, creatinine value is set to 4.0",
    "Laboratory values less than 1.0 are set to 1.0 for calculation",
    "Values should be no more than 48 hours old",
    "Final score is rounded to nearest whole number and bounded between 6-40",
    "Replaced by MELD-Na in 2016 for UNOS allocation"
  ]
}